HealthEquity Inc. (HQY) Receives $36.00 Consensus PT from Analysts
HealthEquity Inc. (NASDAQ:HQY) has earned an average recommendation of “Buy” from the ten ratings firms that are covering the company. Three research analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year is $36.00.
A number of brokerages have issued reports on HQY. Zacks Investment Research raised shares of HealthEquity from a “sell” rating to a “hold” rating in a report on Friday, November 11th. SunTrust Banks Inc. reissued a “buy” rating on shares of HealthEquity in a report on Thursday, September 8th. Barrington Research raised their target price on shares of HealthEquity from $34.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, September 8th. Robert W. Baird raised their target price on shares of HealthEquity from $31.00 to $35.00 and gave the stock a “neutral” rating in a report on Wednesday, September 7th. Finally, JPMorgan Chase & Co. began coverage on shares of HealthEquity in a report on Friday, October 28th. They issued an “overweight” rating and a $43.00 target price on the stock.
HealthEquity (NASDAQ:HQY) opened at 41.16 on Thursday. HealthEquity has a 52-week low of $15.80 and a 52-week high of $41.89. The firm has a market cap of $2.41 billion, a PE ratio of 105.54 and a beta of 1.72. The firm’s 50-day moving average price is $36.24 and its 200 day moving average price is $31.31.
HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, September 6th. The company reported $0.16 EPS for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.03. The business earned $44.20 million during the quarter. HealthEquity had a return on equity of 10.89% and a net margin of 15.21%. The firm’s revenue for the quarter was up 44.9% on a year-over-year basis. During the same quarter last year, the business posted $0.08 earnings per share. On average, equities analysts anticipate that HealthEquity will post $0.42 earnings per share for the current year.
In other HealthEquity news, CFO Darcy G. Mott sold 10,000 shares of HealthEquity stock in a transaction that occurred on Monday, August 22nd. The shares were sold at an average price of $29.13, for a total value of $291,300.00. Following the transaction, the chief financial officer now owns 80,000 shares in the company, valued at $2,330,400. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Stephen Neeleman sold 9,898 shares of HealthEquity stock in a transaction that occurred on Tuesday, August 23rd. The stock was sold at an average price of $30.28, for a total transaction of $299,711.44. Following the completion of the transaction, the insider now owns 9,898 shares in the company, valued at approximately $299,711.44. The disclosure for this sale can be found here. Corporate insiders own 29.00% of the company’s stock.
A number of hedge funds and other institutional investors have recently bought and sold shares of HQY. Louisiana State Employees Retirement System raised its position in HealthEquity by 0.6% in the second quarter. Louisiana State Employees Retirement System now owns 15,700 shares of the company’s stock valued at $477,000 after buying an additional 100 shares during the period. BlackRock Group LTD raised its position in HealthEquity by 13.1% in the first quarter. BlackRock Group LTD now owns 31,745 shares of the company’s stock valued at $783,000 after buying an additional 3,689 shares during the period. Prudential Financial Inc. raised its position in HealthEquity by 8.3% in the first quarter. Prudential Financial Inc. now owns 87,060 shares of the company’s stock valued at $2,148,000 after buying an additional 6,700 shares during the period. Hood River Capital Management LLC raised its position in HealthEquity by 165.1% in the second quarter. Hood River Capital Management LLC now owns 254,750 shares of the company’s stock valued at $7,741,000 after buying an additional 158,650 shares during the period. Finally, Suntrust Banks Inc. acquired a new position in HealthEquity during the second quarter valued at about $499,000. Hedge funds and other institutional investors own 91.12% of the company’s stock.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Stock Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related stocks with our FREE daily email newsletter.